Pharmaceutical companies are closely monitoring the potential effect of the coronavirus on the supply of medicines and raw materials sourced from Asia, SA’s biggest trade association for drug manufacturers said on Wednesday.

Fears of potential medicine shortages have been heightened by India’s announcement on Tuesday that it plans to curtail exports of some common drugs due to growing concerns over a shortage of key ingredients sourced from China, the epicentre of the coronavirus epidemic...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.